12.70

2.23% -0.29

Ginkgo Bioworks Holdings Inc (DNA)

Overview News Price History Option Chain Why DNA Down? Discussions Forecast

Ginkgo Bioworks Holdings Inc stock is traded at $12.70, with a volume of 1.02M. It is down -2.23% in the last 24 hours and down -21.31% over the past month. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Previous Close:

$12.99

Open:

$13

24h Volume:

1.02M

Relative Volume:

0.64

Market Cap:

$597.10M

Revenue:

$217.11M

Net Income/Loss:

$-651.19M

P/E Ratio:

-0.9777

EPS:

-12.99

Net Cash Flow:

$-387.26M

1W Performance:

-5.15%

1M Performance:

-21.31%

6M Performance:

+80.40%

1Y Performance:

+63.87%

1-Day Range:

$12.46

$13.08

1-Week Range:

$11.83

$13.38

52-Week Range:

$5.00

$17.58

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name

Ginkgo Bioworks Holdings Inc

Sector

Healthcare (1139)

Industry

Biotechnology (635)

Phone

(877) 442-5362

Address

27 DRYDOCK AVENUE, BOSTON

Employee

834

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

DNA's Discussions on Twitter

Compare DNA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DNA Ginkgo Bioworks Holdings Inc	12.68	769.00M	217.11M	-651.19M	-387.26M	-12.99
VRTX Vertex Pharmaceuticals Inc	425.68	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.21	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	432.02	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	825.25	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.18	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight
May-18-22	Downgrade	BofA Securities	Neutral → Underperform
Mar-02-22	Resumed	Cowen	Outperform
Feb-23-22	Initiated	Goldman	Neutral
Feb-01-22	Initiated	BofA Securities	Neutral
Jan-28-22	Initiated	BofA Securities	Buy
Jan-07-22	Initiated	BTIG Research	Buy
Nov-29-21	Initiated	Jefferies	Buy
Oct-13-21	Initiated	Raymond James	Outperform
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy

View All

Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News

01:51 AM

Ginkgo Bioworks Wins Project Agreement Through BARDA's BioMaP-Cons Consortium - MarketScreener

01:51 AM

10:08 AM

Real time pattern detection on Ginkgo Bioworks Holdings Inc. stockWeekly Market Report & AI Enhanced Trade Execution Alerts - newser.com

10:08 AM

09:32 AM

Ginkgo Bioworks Holdings Inc. stock daily chart insightsWeekly Trade Review & Real-Time Volume Analysis - newser.com

09:32 AM

08:51 AM

Will Ginkgo Bioworks Holdings Inc. stock gain from lower inflationMarket Volume Report & Weekly High Momentum Picks - newser.com

08:51 AM

08:41 AM

Is it time to cut losses on Ginkgo Bioworks Holdings Inc.Profit Target & Free Growth Oriented Trading Recommendations - newser.com

08:41 AM

08:00 AM

Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium - PR Newswire

08:00 AM

06:30 AM

Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture - MarketScreener

06:30 AM

05:11 AM

Can Ginkgo Bioworks Holdings Inc. stock beat market expectations this quarterWeekly Trend Report & Daily Chart Pattern Signals - newser.com

05:11 AM

01:50 AM

How interest rate cuts could boost Ginkgo Bioworks Holdings Inc. stockShare Buyback & Free Verified High Yield Trade Plans - newser.com

01:50 AM

Nov 02, 2025

Can Ginkgo Bioworks Holdings Inc. Class stock resist broad market declinesJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com

Nov 02, 2025

Live market analysis of Ginkgo Bioworks Holdings Inc.2025 Stock Rankings & Safe Entry Trade Reports - newser.com

Nov 02, 2025

Visual trend scoring systems applied to Ginkgo Bioworks Holdings Inc.Portfolio Performance Report & Daily Volume Surge Trade Alerts - newser.com

Nov 02, 2025

Is Ginkgo Bioworks Holdings Inc. stock dividend yield sustainableQuarterly Trade Review & High Win Rate Trade Tips - newser.com

Nov 02, 2025

Is Ginkgo Bioworks Holdings Inc. Class stock a defensive play amid uncertaintyWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com

Nov 02, 2025

Statistical indicators supporting Ginkgo Bioworks Holdings Inc.’s strengthBear Alert & Verified Swing Trading Watchlists - newser.com

Nov 02, 2025

Ginkgo Bioworks (DNA) Expected to Announce Earnings on Thursday - MarketBeat

Nov 02, 2025

Why Ginkgo Bioworks Holdings Inc. Class stock fits value portfoliosSwing Trade & Safe Investment Capital Preservation Plans - newser.com

Nov 02, 2025

Nov 01, 2025